Bausch Health releases inaugural Environmental, Social and Governance Report
As our world continues to transform at an unprecedented pace, we remain committed to our mission of
improving people’s lives with our health care products. An integral part of our ability to achieve our mission is a
focus on sustainability, and in identifying current and emerging environment, social and governance trends. Doing so
plays a key role in helping us understand the needs of our patients and customers, and in ensuring the viability of
our own business.
Last year was one we will never forget. The global COVID-19 pandemic impacted our businesses around the
world as social unrest weighed on many of our colleagues, our communities and our customers. It was a trying and
anxious year for all.
Throughout the pandemic, our top priorities have been to make sure that our employees were safe and that
we were able to maintain a steady supply of our medicines and health care products to the more than 150 million
people around the world who rely on them every day. We continued to support patients and offered certain of our
prescription medicines free of charge through our Bausch Health Patient Assistance Program, especially to those who
may have lost their health insurance during the pandemic. Finally, we initiated clinical trials to find new methods
to treat COVID patients and donated products to health care practitioners and frontline workers.
We further strengthened our focus on Diversity, Equity & Inclusion with additional programs and
training. We are dedicated to fostering a work environment where everyone feels welcomed, supported and valued for
their talents and contributions. Within this report, we also further discuss our Employee Resource Groups, which
provide opportunities for professional growth, development and informal networking.
Our focus on reducing the environmental impact of our operations continues to yield impressive results.
For example, over the past three years, we reduced monthly water consumption by some 40% and the amount of solid
waste generated monthly by nearly 80%, as well as a more than 60% increase in waste that is reused or recycled
Another aspect of the transformation I referenced earlier in this letter is the continued stakeholder
scrutiny around Environment, Social and Governance (ESG) performance. While our organization has had a longstanding
commitment to sustainability initiatives, in 2021 we are undertaking an initiative to better understand how they
drive our long-term business and strategies.
As part of our work to formalize our ESG efforts, we’ve made the decision to rebrand our Corporate
Social Responsibility Report to an Environment, Social and Governance Report, as we believe this better reflects our
incorporation of these areas as core to our business, as well as our expanded scope of associated activities. We are
taking steps to organize a more robust ESG program with the full participation of our Board of Directors and
Executive Committee, as well as outside advisors. Specific outputs of this work include:
- Establishing a cross-functional ESG Steering Committee
- Rolling out an ESG Scorecard and
- Creating an ESG Reporting Strategy
And, we will leverage this initiative as we continue our efforts to separate into three strong,
independent companies with their own integrated ESG programs. To guide our efforts, we will conduct a materiality
process where we will engage key stakeholders to help build a more strategic approach to managing and tracking our
performance against priority sustainability issues. We expect to report on our progress in much greater detail in
the months to come.
Together with the contributions of our Bausch Health colleagues and support of our stakeholders, we
continue to grow our organization into an innovative company dedicated to advancing global health. It is our hope
that this inaugural ESG Report provides a picture of our current and forward-looking sustainability efforts and
Joseph C. Papa
Chief Executive Officer and Chairman of the Board